1 completed, 1 not yet recruiting, 1 unknown. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Not yet recruiting 1, Unknown 1 |
Follow DWP14012 20mg: new trials by email Literature Review of DWP14012 20mg trials Research Report on DWP14012 20mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of DWP14012 for Long-Term Maintenance Therapy in Patients With Healed Erosive Esophagitis DWP14012 20mg, DWP14012 20 mg placebo, DWC202517 15 mg - Healed Erosive Esophagitis | Phase 3 | Not yet recruiting | Daewoong Pharmaceutical Co. LTD. | 420 | 2026-09-01 | 2026-08-13 |
| Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-Erosive Gastroesophageal Reflux Disease (NERD) DWP14012 20mg, DWP14012 40mg, Placebo - Non-erosive Reflux Disease, Non-Erosive Gastro-Esophageal Reflux Disease | Phase 3 | Unknown | Daewoong Pharmaceutical Co. LTD. | 324 | 2023-08-31 | 2023-11-08 |
| Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic Ulcer DWP14012 20mg, Lansoprazole 15 mg, DWP14012 20mg placebo - Peptic Ulcer | Phase 3 | Completed | Daewoong Pharmaceutical Co. LTD. | 423 | 2021-05-21 | 2024-07-08 |
Non-Erosive Reflux Disease (1) · Peptic Ulcer (1)
Daewoong Pharmaceutical Co. LTD. (3)
South Korea (2)